The impact of facility characteristics on Merkel cell carcinoma outcomes: a retrospective cohort study.
Previous work has suggested that facility-level characteristics such as case volume and academic affiliation are associated with patient survival for rare malignancies. Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer with high mortality and rising incidence. The impact of facility characteristics on MCC outcomes is not yet established. We aimed to investigate the association of facility academic affiliation and case volume with MCC patient survival. We conducted a retrospective cohort analysis of US adult MCC cases diagnosed from 2004-2014 in the NCDB. Both facility academic affiliation (p<0.001) and case volume (p<0.001) were significantly associated with patient survival. For propensity score-matched cohorts of patients treated at academic versus non-academic facilities, five-year survival was 63.0% (SE: 1.7) and 53.4% (SE: 1.9) respectively. Five-year survival for propensity score-matched cohorts of patients treated at high versus low/intermediate case volume facilities was 67.4% (SE: 2.1) and 58.6% (SE: 2.0) respectively. Disease-specific survival and local recurrence data were not available. Treatment of MCC at academic and high-volume centers is associated with significantly improved patient survival. Further study, taking into account comorbidities and evaluating disease-specific survival, is needed to establish whether experienced centers have improved outcomes in MCC treatment.